Mesalamine Long-Acting Capsules (Delzicol) and Mogamulizumab-kpkc
Determining the interaction of Mesalamine Long-Acting Capsules (Delzicol) and Mogamulizumab-kpkc and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mesalamine
Brand name: Apriso, Asacol HD, Delzicol, Lialda, Pentasa, Canasa, Canasa Pac, Rowasa, SfRowasa
Synonyms: Mesalamine
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mesalamine Long-Acting Capsules (Delzicol)-Mogamulizumab-kpkc Intravenous
- Mesalamine Long-Acting Capsules (Delzicol)-Molindone
- Mesalamine Long-Acting Capsules (Delzicol)-Mometasone (Oral Inhalation)
- Mesalamine Long-Acting Capsules (Delzicol)-Mometasone and Formoterol
- Mesalamine Long-Acting Capsules (Delzicol)-Mometasone and formoterol Inhalation
- Mesalamine Long-Acting Capsules (Delzicol)-Mometasone Cream
- Mogamulizumab-kpkc-Mesalamine Long-Acting Capsules (Pentasa)
- Mogamulizumab-kpkc-Mesalamine rectal
- Mogamulizumab-kpkc-Mesalamine Rectal Enema
- Mogamulizumab-kpkc-Mesalamine Rectal Suspension
- Mogamulizumab-kpkc-Mesalamine Suppositories
- Mogamulizumab-kpkc-Mesalamine Suppository